ScoreWhy is Jiangsu Hengrui Pharmaceuticals Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 3.76% and Operating profit at 4.45% over the last 5 years
2
The company declared negative results in Mar'25 after positive results in Dec'24
- INTEREST(9M) At CNY 12.35 MM has Grown at 272.72%
- OPERATING PROFIT(Q) Lowest at CNY 1,285 MM
- OPERATING PROFIT MARGIN(Q) Lowest at 17.3 %
3
With ROE of 12.29%, it has a very expensive valuation with a 8.72 Price to Book Value
- Over the past year, while the stock has generated a return of 16.75%, its profits have risen by 32.1% ; the PEG ratio of the company is 2.2
- At the current price, the company has a high dividend yield of 0.3
4
Majority shareholders : Non Institution
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Jiangsu Hengrui Pharmaceuticals Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Jiangsu Hengrui Pharmaceuticals Co., Ltd. for you?
Medium Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
-5.5%
0.87
31.38%
China Shanghai Composite
19.22%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
2.25%
EBIT Growth (5y)
5.77%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.56
Tax Ratio
12.26%
Dividend Payout Ratio
17.74%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
99,562.58%
ROE (avg)
135,472.87%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
37
Industry P/E
Price to Book Value
4.60
EV to EBIT
29.58
EV to EBITDA
27.30
EV to Capital Employed
10.94
EV to Sales
7.74
PEG Ratio
2.36
Dividend Yield
0.44%
ROCE (Latest)
37.00%
ROE (Latest)
12.33%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 11,499.87 MM
DEBTORS TURNOVER RATIO(HY)
Highest at 4.7 times
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
RAW MATERIAL COST(Y)
Fallen by -3.42% (YoY
CASH AND EQV(HY)
Highest at CNY 81,705.12 MM
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Debtors Turnover Ratio
Highest at 4.7 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Operating Cash Flow
Highest at CNY 11,499.87 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Cash and Eqv
Highest at CNY 81,705.12 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -3.42% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
